Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium
other · Food and Drug Administration · Rule · Published 2010-01-11 · Effective 2010-01-11 · 75 FR 1274
Document
Document number
2010-207
Federal Register citation
75 FR 1274
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2010-01-11
Effective date
2010-01-11
HHS docket
Docket No. FDA-2009-N-0665
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Anika Therapeutics, Inc. The supplemental NADA provides for a revised human food safety warning for use of hyaluronate sodium injectable solution in horses.